SUBSCRIBE

CATEGORIES

4 Unstoppable Biotech Stocks to Buy Right Now

imageStock Markets20 minutes ago (Jun 30, 2021 05:30PM ET)

(C) Reuters. 4 Unstoppable Biotech Stocks to Buy Right Now

The increasing demand for drugs and therapies for critical diseases for an aging population in several economies should drive the biotech industry over the long term. So, fundamentally sound biotech companies Amgen (AMGN), Gilead (GILD), Illumina (NASDAQ:ILMN), and Regeneron (NASDAQ:REGN) are well-positioned to capitalize on the industry tailwinds. Thus, we think their stocks should continue gaining. Read on.Biotech companies are currently focused on developing viable drugs, therapies and medical diagnostics tests to treat critical diseases and serious ailments through tech integration. Investors have been betting on the biotech space to reap substantial returns over the long term, given the aging population and inelastic demand for medication. This is evidenced by the iShares Nasdaq Biotechnology ETF’s (IBB) 7.7% returns over the past month versus the SPDR S&P 500 Trust ETF’s (SPY) 1.8% gains.

With biotech companies leveraging next generation technology and genome mapping methods to revolutionize healthcare, the global biotechnology market is expected to grow at a 15.5% CAGR to hit $850.50 billion by 2027.

Therefore, we believe the shares of fundamentally sound biotechnology stocks Amgen Inc . (NASDAQ:AMGN), Gilead Sciences Inc . (NASDAQ:GILD), Illumina, Inc. (ILMN), and Regeneron Pharmaceuticals, Inc. (REGN) have the potential to continue soaring.

Continue reading on StockNews

4 Unstoppable Biotech Stocks to Buy Right Now

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.